Implementation of quality by design and green chemistry principles to validate the stability indicating method on UHPLC for the simultaneous quantification of Glycopyrronium, Fluticasone, Vilanterol in inhaled formulation
Open Access
- 5 October 2024
- journal article
- research article
- Published by Elsevier in Green Analytical Chemistry
- Vol. 11
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Route optimization on selectivity and kilogram-scale synthesis of Vilanterol TrifenatateTetrahedron, 2023
- Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis CACS Omega, 2022
- Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-AnalysisAdvances in Therapy, 2022
- Eco-friendly chiral HPLC method for determination of alfuzosin enantiomers and solifenacin in their newly pharmaceutical combination: Method optimization via central composite designMicrochemical Journal, 2021
- A combined approach of green chemistry and Quality-by-Design for sustainable and robust analysis of two newly introduced pharmaceutical formulations treating benign prostate hyperplasiaMicrochemical Journal, 2021
- HPLC-UV and spectrofluorimetric methods for simultaneous estimation of fluticasone furoate and vilanterol in rabbit plasma: A pharmacokinetic studyJournal of Chromatography B, 2019
- Glycopyrronium/Formoterol: A Review in COPDDrugs, 2019
- Pharmacology, toxicology and clinical safety of glycopyrrolateToxicology and Applied Pharmacology, 2019
- Fluticasone Furoate/Vilanterol: a Review of Its Use in Patients with AsthmaDrugs, 2015
- Fluticasone Furoate/Vilanterol: A Review of Its Use in Chronic Obstructive Pulmonary DiseaseDrugs, 2014